After week 8, the CD68+ surface area decreased significantly by 74% (p < 0.01) and 83% (p < 0.01), in Sham and CKD, respectively (Sham 12 weeks 2.4 ± 0.6%—CKD 12 weeks 1.42 ± 0.4%). This evidence concerns the gene CD68 and chronic kidney disease.